Neonatal screening in New Zealand

BMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7026.312 (Published 03 February 1996) Cite this as: BMJ 1996;312:312
  1. Dianne Webster,
  2. Charles Essex
  1. Director National Testing Centre, PO Box 872, Auckland, New Zealand
  2. Consultant community paediatrician Child Development Unit, Gulson Hospital, Coventry CV1 2HR

    EDITOR,—Alison Streetly and colleagues describe the neonatal screening programmes in the United Kingdom.1 Screening for phenylketonuria and congenital hypothyroidism is almost universal, but other conditions have been added to meet regional needs (or regional skills and interests). The authors comment that not all programmes have been assessed against the criteria that determine whether a screening programme is suitable.2

    In New Zealand seven conditions are screened for (table 1), with roughly 95% coverage of about 60000 births annually. Some of the …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription